Pesticides based on microorganisms and their products have proven to be highly effective, species specific and eco-friendly in nature, leading to their adoption in pest management strategies around the world. The microbial biopesticide market constitutes about 90% of total biopesticides and there is ample scope for further development in agriculture and public health, although there are challenges as well. This article reviews the various microbial biopesticides that are commercially available, the different approaches for their production and development, the recent technological advances and the challenges faced by the microbial biopesticide field in the future.
Introduction
The damage and destruction inflicted on crops by pests have had a serious impact on farming and agricultural practices for a long time. These pests include insects, fungi, weeds, viruses, nematodes, animals and birds. It has been estimated that nearly 10 000 species of insects, 50 000 species of fungi, 1800 species of weeds and 15 000 species of nematodes destroy food and fibre crops used by millions of people worldwide. In India alone, 30% of the crop yield potential is lost as a result of insects, disease and weeds, corresponding to 30 million tons of food grain. In an attempt to avoid such losses, the primary strategy employed has been to eliminate the pests by using chemical pesticides such as chlorinated hydrocarbons, organophosphates and carbamates. However, despite the successes achieved, potential hazards or risks have emerged that have had a substantial impact on the environment; compounded further by indiscriminate and excessive use of the products. Consequently, beneficial species have been lost and residual problems have increased, with subsequent impact on the food chain, groundwater contamination and resistance in pests. To overcome the hazards associated with chemical pesticides, the use of biopesticides (pesticides derived from such natural materials as animals, plants, microorganisms and certain minerals) is increasingly being adopted. North America uses the largest percentage of the biopesticide market share at 44%, followed by the EU and Oceania with 20% each, South and Latin American countries with 10% and about 6% in India and other Asian countries [1, 2] . In terms of sales of biopesticides, the global market in 2007 was US$672 million and projected as US$1000 million for 2010 ( Figure 1 ). The current growth of the chemical pesticide market is about 1-2% per year, while growth in microbial pest control is about 10% per year (with some estimates projecting growth as high as 20%) [3] . As of 2007/08, estimates of microbial biopesticide sales were US$396 million at the end-user level, although these estimates are likely to be just a fraction of the total usage of such products, owing to the lack of information available on the non-commercial use of such products in these regions. Such estimates could be more unreliable globally, given unquantified sales in other parts of the world. A recent survey has shown that Europe is a large, intense and diverse pesticide market valued at $12850 million in 2008; approximately 31.7% of the world's total.
The six largest national agrochemical markets are in amounts; Denmark, Estonia, Finland, Lithuania, Norway and Sweden combined use just 2.2% of the total [4] . Over the past 150 years, a great deal of knowledge has been gathered on the use of microorganisms including bacterial, fungal, viral, protozoan or nematode-based preparations as pest control agents (see Box 1) . However, the widespread use of biopesticides has been restricted, owing to various constraints at the developmental, registration and production levels. Assessment of the use of microorganisms in pest management suggests that advances have been incremental, rather than transformative. This is apparently the result of higher production costs in comparison with conventional chemical pesticides, narrow target-species ranges and inefficient delivery systems. Although there have been ample advances in terms of new discoveries of microbial isolates and an increasing ability to genetically manipulate the microbial agents involved, concerns about pest resistance and environmental and human safety remain. Furthermore, increased adoption of microbial biopesticides has come under threat from the development of new biorational pesticides (including pest control agents, and chemical analogues of naturally occurring biochemicals such as pheromones, insect growth regulators, etc., which are more environment friendly than synthetic chemical pesticides). Comparative analyses of conventional insecticides with microbial biopesticides (see Box 2) suggest that there is still a lack of knowledge regarding the interactions of microbial biopesticides with pests, natural enemies and the wider ecosystem. Microbial control agents, based on naturally occurring fungi, bacteria, viruses or nematodes have offered some realistic alternatives to chemical pesticides when used as part of an ecologically based integrated pest management (EBIPM) or area-wide pest management strategy (AWPM) [5, 6] . There are many reasons for the recent increased interest in microbial biopesticides, including the development of resistance to conventional synthetic pesticides, a decline in the rate of discovery of novel insecticides, increased public perception of the dangers associated with synthetic pesticides, host-specificity of microbial pesticides and improvement in the production and formulation technology of microbial biopesticides.
In view of various opportunities and challenges that are associated with the development of microbial biopesticides, this article reviews the commercially available microbial biopesticides, the different approaches for their production and development, the technological advances made and constraints envisaged in future in the field of microbial biopesticides.
Microbial Biopesticides in Pest Management
Out of all the biopesticides used today, microbial biopesticides constitute the largest group of broad-spectrum biopesticides, which are pest specific (i.e., do not target non-pest species and are environmentally benign). There are at least 1500 naturally occurring insect-specific microorganisms, 100 of which are insecticidal [2] . Over 200 microbial biopesticides are available in 30 countries affiliated to the Organization for Economic Co-operation and Development (OECD) [7] . There are 53 microbial biopesticides registered in the USA, 22 in Canada and 21 in the European Union (EU) [8, 9] although reports of the products registered for use in Asia are variable [10] . Overall, microbial biopesticide registrations are increasing globally, the expansion of various technologies has increased the scope for more products and the change in the trend to develop microbial products is definitely on the rise [1, 11] .
Bacterial Biopesticides
The bacteria that are used as biopesticides can be divided into four categories: crystalliferous spore formers (such as Bacillus thuringiensis); obligate pathogens (such as Bacillus popilliae); potential pathogens (such as Serratia marcesens); and facultative pathogens (such as Pseudomonas aeruginosa).
Out of these four, the spore formers have been most widely adopted for commercial use because of their safety and effectiveness. The most commonly used bacteria are B. thuringiensis and Bacillus sphaericus. B. thuringiensis is a specific, safe and effective tool for insect control [12] . It is a Gram-positive, spore-forming, facultative bacterium, with nearly 100 subspecies and varieties divided into 70 serotypes [13] . The insecticidal property of B. thuringiensis resides in the Cry family of crystalline proteins that are produced in the parasporal crystals and are encoded by the cry genes. The Cry proteins are globular molecules (65-145 kDa, depending on the strain) with three structural domains connected by single linkers. The 200 Cry Agostino Maria Bassi (called the Father of Insect Pathology) published his work on white muscardine disease of the silkworm and the fungus responsible for this disease was later on named as B. bassiana (Balsamo) Vuillemin [135] .
The first published record of a diseased insect appears to be that of the 'Chinese plant worm', described and illustrated by Rene-Antoine Ferchault de Reaumur in 1726. He understood the `stemlike vegetable growth', emerging from a noctuid larva to be the root of a plant. In 1749, a Franciscan friar in Cuba described dead wasps with little trees growing out of their bellies. This was a fungus now known as a member of the genus Cordyceps [136] . During the midnineteenth to early-twentieth centuries, numerous scientists reported on the biology and pathology of the entomopathogenic fungi who recommended study of fungal epizootics of insect to determine the most effective means of introducing and transmitting such pathogens.
A Russian entomologist, Metschnikoff, conducted the first systematic experiments on the control of injurious insects with microorganisms by infecting grubs of the grain beetle, Anisoplia austriaca, with the green muscardine fungus, M. anisopliae (Metschnikoff) Sorokin, in 1879. The fungus was found to be even more effective against the sugar beet curculio, Cleonus punctiventris (Germ.). A Japanese scientist, who named it Bacillus sotto, first discovered a bacterium in silkworms in 1901 but it was 10 years later that a German scientist, Ernst Berliner, isolated the bacterium from diseased flour moths and assumed it was responsible for the suddencollapse disease, which was affecting the insect. Since he had obtained the first sample from a mill in Thuringia, he called the bacterium Bacillus thuringiensis (Bt).
Field trials with Bt to control the European corn borer were conducted as early as the late 1920s and in 1938 the first commercial Bt preparation (Sporeine) came on to the market in France. However, it was not until the 1960s that its use became widespread. In 1964, Biospor became the first Bt preparation to be licensed as a pesticide in Germany. Another breakthrough in the development of microbial control came with the discovery and practical application of the milky disease bacteria, Bacillus popilliae Dutky, for the control of the Japanese beetle, Popillia japonica Newman on turfs in USA during 1940s [137] . But with the discovery in 1970 of the particularly virulent Bt strain B. thuringiensis kurstaki, which is effective against the larvae of certain butterflies and moths, and the discovery in 1983 of the B. thuringiensis tenebrionis strain, which is effective against certain beetles, including the Colorado potato beetle, the range of microbial agents available has grown considerably. 50 subgroups [14] . This three-domain family is characterized by protoxins of two different lengths, one being longer with a C-terminal extension necessary for toxicity.
This extension also has a characteristic role in crystal formation within the bacterium [15] . Cry proteins are responsible for feeding cessation and death of the insect and their biology has been comprehensively described [2] .
Cry protoxins are ingested [13, 16] and then solubilized (some toxin families need more alkaline pH and others respond more to neutral pH), releasing a proteaseresistant biologically active endotoxin, before being digested by protease of the gut to remove amino acids from its C-and N-terminal ends. The C-terminal domain of the active toxin binds to specific receptors on the brush border membranes of the midgut followed by the insertion of the hydrophobic region of the toxin into the cell membrane [17] . This creates a disruption in the osmotic balance, because of the formation of transmembrane pores and ultimately cell lysis occurs in the gut wall, leading to leakage of the gut contents ( Figure 2 ). This induces starvation and lethal septicaemia of the target pest.
Many details of this process are still not understood and the action seems to be more complex as indicated by the existence of novel receptors and signal transduction pathways induced within the host following intoxication [18] . This could lead to altered activation of midgut proteases, resulting in differences in the toxin structure that could affect binding to the peritrophic membrane, thereby accounting for host specificity [19] Some insects develop resistance to several insect pathogens. Resistance management will have to be practiced, as it is with chemical pesticides.
Chemical Pesticides

Advantages
Chemical pesticides are cost-effective and economical to control pests. Low labour input is required and they allow large areas to be treated quickly and effectively. Estimates suggest that 4-fold returns are expected after the use of these pesticides.
Chemical pesticides are flexible in the sense that they control all pests with variation in type, activity and persistence.
They are easily available in large quantities, at high quality and at reasonable price.
Pesticides are often used to stop the spread of pests in imports and exports, preventing weeds and protecting households from destruction. They have substantial application in protection of pets and humans from pests.
Disadvantages
Reduction in beneficial insects due to the toxicity of these pesticides to non-target pests can result in changes in biodiversity of an area and affect natural biological balance. Drift of sprays and vapour of chemical pesticides can cause severe problems in different crops, waterways and general environment. Chemical pesticides do leave residues in food, either by direct application or by bio-magnification. Because of their persistent use in agriculture, chemicals can reach underground aquifers and contaminate water bodies. There are poisoning hazards for pesticide operators given excessive exposure; though it depends on dose, toxicity, sensitivity and duration of exposure. Overuse of chemical pesticides encourages resistance. israelensis has been estimated as US$ 1.2 and 0.01 using commercial complex medium versus by-products of industrial factories, respectively. Some common commercial products based on Bacillus thuringiensis are available globally (Table 1) .
B. sphaericus is a Gram-positive strict aerobic bacterium, which produces round spores in a swollen club-like terminal or subterminal sporangium [20] . B. sphaericus strains were isolated in the mid-1960s from mosquitoes, blackflies and grasshoppers [21] . These bacteria produce an intracellular protein toxin (5511-1) and a parasporal crystalline toxin at the time of sporulation [22] . The mosquito-larvicidal binary toxin produced by B. sphaericus is composed of BinB and BinA, 51.4 and 41.9 kDa, respectively. Bin proteins in combination form a crystal and in solution can exist as an oligomer containing two copies each of BinB and BinA [23, 24] . Some toxic strains also produce 100 kDa toxins encoded by mtx genes [25] . Bacillus-sphaericus-based products are commonly used for mosquito control (Table 1) .
Other species of bacteria have little impact on pest management though some commercial products based on Agrobacterium radiobacter, B. popilliae, B. subtilis, P. seudomonas cepacia, P. seudomonas chlororaphis, P. seudomonas flourescens, P. seudomonas solanacearum and P. seudomonas syringae are available (Table 1 ).
Viral Biopesticides
Over 700 insect-infecting viruses have been isolated, mostly from Lepidoptera (560) followed by Hymenoptera (100), Coleoptera, Diptera and Orthoptera (40) [2] .
About a dozen of these viruses have been commercialized for use as biopesticides ( Figure 2 ). Infected nuclei can produce hundreds of polyhedra and thousands of granules per cell. These can create enzootics, deplete the pest populations, and ultimately create a significant impact on the economic threshold of the pest. The viral biopesticides are usually only active against a narrow host spectrum and after their application to plant surfaces, and baculovirus occlusion bodies (OBs) are rapidly inactivated by solar ultraviolet (UV) radiation, particularly in the UV-B range of 280-320 nm [28] .
However, their efficacy can be improved by the use of formulations that include stilbene-derived optical brighteners, which increase susceptibility to NPV infection by disrupting the peritrophic membrane [29] or inhibiting sloughing [30] or virus-induced apoptosis of insect midgut cells [31] . UV inactivation could be controlled by creating systems, which can filter UV radiation, as has been demonstrated by using plastic greenhouse structures that reduced the intensity of incident UV-B (280-315 nm)
readings by >90% compared with external readings leading to an increase in the prevalence of infection in larvae [32] .
Fungal Biopesticides
The pathogenic fungi are another group of microbial pest management organisms [2] that grow in both aquatic as well as terrestrial habitats and when specifically associated Opender Koul 5 with insects are known as entomopathogenic fungi. These are obligate or facultative, commensals or symbionts of insects. The pathogenic action depends on contact and they infect and kill sucking insect pests such as aphids, thrips, mealy bugs, whiteflies, scale insects, mosquitoes and all types of mites [33, 34] . Entomopathogenic fungi are promising microbial biopesticides that have a multiplicity of mechanisms for pathogenesis. They belong to 12 classes within six phyla and belong to four major groups; Laboulbeniales, Pyrenomycetes, Hyphomycetes and Zygomycetes. Some of the most widely used species include Beauveria bassiana, Metarhizium anisopilae, Nomuraea rileyi, Paecilomyces farinosus and Verticillium lecanii.
Many of them have been commercialized globally ( Table 1 ).
These fungi attack the host via the integument or gut epithelium ( Figure 2 ) and establish their conidia in the joints and the integument [35] . Some species such as B. bassiana and M. anisipoliae cause muscardine insect disease and after killing the host, cadavers become mummified or covered by mycelial growth [36] . Some fungi, primarily streptomycetes, also produce toxins that act against insects [37] . About 50 such compounds have been reported as active against various insect species belonging to Lepidoptera, Homoptera, Coleoptera, Orthoptera and mites [38] . The most active toxins are actinomycin A, cycloheximide and novobiocin. Spinosyns are commercially available biopesticidal compounds that were originally isolated from the actinomycete Saccharopolyspora spinosa [39] and are active against dipterans, hymenopterans, siphonaterans and thysanopterans but are less active against coleopterans, aphids and nematodes [39] .
Nematode Biopesticides
Another group of microorganisms that can control pests is the entomopathogenic nematodes, which control weevils, gnats, white grubs and various species of the Sesiidae family [40] [41] [42] [43] . These fascinating organisms suppress insects in cryptic habitats (such as soil-borne pests and stem borers). Commonly used nematodes in pest management belong to the genera Steinernema and Heterorhabditis, which attack the hosts as infective juveniles (IJs) [44, 45] . IJs are free-living organisms, which enter the hosts through mouth, anus, spiracles or cuticle ( Figure 2 ). They are able to release their bacterial symbionts in to the haemocoel of hosts, killing the host within 24-48 h [46] . The nematodes can complete up to three generations within the host, after which the IJs leave the cadaver to find the new hosts [44] . Entomopathogenic nematodes (EPN) can be mass-produced in vivo and in vitro in solid media or liquid fermentation [47] [48] [49] . Nematodes that have been successfully produced in fermenters (7500-80 000-litre capacity) include Steinernema carpocapsae, S. riobrave, Steinernema glaseri, Steinernema scapterisci, Heterorhabditis bacteriophora and Heterorhabditis megidis, with a yield capacity up to 250 000 IJs /ml [49, 50] . The use of nematodes is done using a curative rather than prophylactic approach [42] , for instance, as demonstrated in the case of Synanthedon exitiosa, using S. carpocapsae and H. bacteriophora nematode species to induce field suppression of the pest in a curative manner [51] ; 1 50 000-300 000 Us/tree were used three times during September and October for three consecutive years in order to obtain as much control as was achieved with chemical pesticides. Some commercial products are available based on Steinernema and Heterorhabditis nematode formulations (Table 1) . However, extensive studies are required to optimize application parameters and develop efficient strains to achieve significant control of pests through nematodes.
Protozoan Biopesticides
Although they infect a wide range of pests naturally and induce chronic and debilitating effects that reduce the target pest populations, the use of protozoan pathogens as biopesticide agents has not been very successful. Protozoa are taxonomically subdivided into several phyla, some of which contain entomogenous species. Microsporan protozoans have been investigated extensively as possible components of integrated pest management programmes. Microsporidia are ubiquitous, obligatory intracellular parasites that are disease agents for several insect species. Two genera, Nosema and Vairimorpha, have some potential as they attack lepidopteran and orthopteran insects and seem to kill hoppers more than any other insect [52] .
A study of Nosema pyrausta, a microsporidium infecting the European corn borer, Ostrinia nubilalis, suggests that in a horizontal transmission, a spore is eaten by a European corn borer larva, which germinates in the midgut, extrudes a polar filament and injects sporaplasm into a midgut cell. The sporaplasm reproduces and then forms more spores, which can infect other tissues. Spores in infected midgut cells are sloughed into the gut lumen and are eliminated along with faeces to the maize plant. These spores remain viable and are consumed during larval feeding so that the infection cycle is repeated in midgut cells of the new host. If a female larva is infected, Nosema is passed to the filial generation by vertical transmission.
As the infected larva develops through to an adult the ovarial tissue and developing oocytes become infected with N. pyrausta. The embryo is infected within the yolk and when larvae hatch, they are infected with N. pyrausta. Both horizontal and vertical transmissions maintain N. pyrausta in natural populations of European corn borer. [53] .
The only protozoan registered for use as a biopesticide is the microsporidian, Nosema locustae, which infects grasshoppers (Table 1 ). This organism is most effective when ingested by nymphal stages of grasshoppers and kills them within three to 6 weeks post-infection [53] .
However, not all infected grasshoppers are killed by this protozoan infection.
Microbial Products in Biopesticides
In addition to the proteinaceous toxins, microorganisms are also known to produce anti-pest chemical com- Some transgenic crops can be considered among microbially based products. Since 1996, more than 200 million ha of land has been planted with Bacillusthuringiensis-based (Bt) genetically engineered crops [56] . While 29 countries planted commercialized biotech crops in 2010, an additional 32 countries, have granted regulatory approval for biotech crops for import of food and feed use and release into the environment since 1996. Varieties of these crops produce 18 different combinations of 11 B. thuringiensis toxins, which kill lepidopteran and coleopteran insects. Bt cotton and maize have been successful and other crops such as transgenic rice, soyabean and rapeseed are making some headway.
Commercial growing was reported in 2009 of smaller amounts of genetically modified (GM) sugar beet, papaya, squash (zucchini), sweet pepper, tomato, petunia, carnations, rose and poplar [57] . Recently, some research and development has been targeted to enhance crops that are locally important in developing countries, such as insectresistant cowpea for Africa [58] and insect-resistant brinjal (eggplant) for India [59] . The European Commission has recently approved Annflora: a GM potato developed by German chemical company BASF, which is the first GM crop to be approved for cultivation in the EU for 12 years, after Monsanto's MON 810 maize, which is engineered to be resistant to the European corn borer caterpillar, was licensed in 1998 [60] .
Genetic Improvement Bacteria
The genetic improvement of microbial pathogens aims to make them more effective by increasing their rate of reproduction, speed of transmission and infective ability or increasing the quantity of toxin produced. For example, genetic transformation of B. thuringiensis has produced a strain that displays insecticidal activity against both coleopteran and lepidopteran insects [61] . The activity of B. thuringiensis on the crop foliage or applications via soil can also be enhanced by genetic manipulation. For instance, B. thuringiensis crystal proteins of the Cry34 and Cry35 classes function as binary toxins showing activity on the western corn rootworm, Diabrotica virgifera virgifera. Cry34A/Cry35A pairs are more active than the Cry34B/ Cry35B pairs. The binary Cry34/Cry35 B. thuringiensis crystal proteins are closely related to each other, are environmentally ubiquitous and share sequence similarities consistent with activity through membrane disruption in target organisms. Modified Cry35 proteins whose segments, domains and motifs have been exchanged with other proteins to enhance insecticidal activity can provide excellent control of plant pests and rootworms [62] .
Similarly, Cry8Bb1 toxin polypeptide from B. thuringiensis has been engineered to contain a proteolytic protection site, which makes it insensitive to a plant protease, helping to protect the toxin from any proteolytic inactivation. Modified Cry8Bb1 has been used for controlling corn rootworms, wireworms, boll weevils, Colorado potato beetles and the alfalfa weevils [63] .
A recent study shows that B. cereus group genomes have a Bacillus enhancin-like (bel) gene, which has potential to increase the insecticidal activity of B. thuringiensis-based biopesticides and transgenic crops based on B. thuringiensis genes [64] . Bel genes encode peptides, which have 20-30% similarity with viral enhancin protein. These proteins are known to enhance viral infections as they degrade the peritrophic matrix of insect midguts. The combination of Bel and Cry1Ac increased the mortality rate 2.2-fold [64] .
Viruses
Use of recombinant baculovirus technology has a potential to produce economical substitutes. Recombinant baculoviruses (vEV-Tox34) expressing the gene Tox-34 from a mite, Pyemotes tritici, increased the speed of kill of the corn earworm, Helicoverpa zea [65] . Similarly, two genetically enhanced isolates of the Autographa califomica nuclear polyhedrosis virus (AcMNPV) expressing insect-specific neurotoxin genes from the spiders Diguetia canities and Tegenaria agrestis (designated vAcTaITX-1 and vAcDTX9.2, respectively) have been evaluated for their commercial potential against lepidopteran insects. While Opender Koul 15 vAcTaITX-1 kills faster than vAcDTX9.2, the latter is a faster feeding deterrent, suggesting that it would be more useful in reducing crop damage [66] . However, developing cost-effective methods for producing recombinant BVs is very challenging because DNA preparations from these viruses and their transfection are very labour intensive and time consuming.
Lymantria dispar multicapsid nucleopolyhedrovirus (LdMNPV) is used on a limited basis as a gypsy moth (L. dispar) control agent. In an effort to improve the efficacy (i.e., killing speed) of the LdMNPV, a recombinant viral strain (vEGT-) that does not produce the enzyme ecdysteroid UDP-glucosyltransferase (EGT) was developed. LT50 values of fifth-instar larvae infected with vEGTwere 33% lower when compared with larvae infected with a wild virus strain. In addition, Buthus eupeus insect toxin-1, the Manduca sexta diuretic hormone, the B. thuringiensis ssp. kurstaki HD-73 delta-endotoxin, the Heliothis virescens juvenile hormone esterase, the P. tritici TxP-I toxin, Androctonus australis neurotoxin, Doi m V gene and T-urf 13 genes have been inserted into BVs for the purpose of developing viral pesticides [67] .
Entomopathogenic Nematodes
In the case of entomopathogenic nematodes, artificial selection has been successful in increasing infectivity and nematicide resistance [68] . The strain selection has shown a gain of fitness with regard to host penetration and reproductive potential. The recent discovery that maize roots damaged by the western corn rootworm emit a key attractant for insect-killing nematodes has opened the way to explore whether a selection strategy can improve the control of root pests [69] . Salame et al. [70] bred a heterogeneous population of Steinernema feltiae for desiccation tolerance and host-seeking ability after 10 to 25 selection cycles. However, artificial selection for one trait may come at a cost for other important traits such as infectiousness, establishment and/or persistence in the field. Using information from the sequenced genomes of EPN may enable the production of GM nematodes with higher storage stability, higher resistance to environmental stresses and higher biological control potential to be developed in the near future [71] [72] [73] .
Entomopathogenic Fungi
Two commonly used entomopathogenic fungi, Metarhizium anisopliae and B. bassiana have been extensively studied for elucidation of pathogenic processes and manipulation of the genes of the pathogens to improve biocontrol performance [74] . Additional copies of the gene encoding the regulated cuticle-degrading protease Pr1 were inserted into the genome of M. anisopliae and overexpressed. The resultant strain reduced survival time which ultimately lead to the development of transgenics. However, the case study presented here is different and related to the discovery and commercialization of a microbial biopesticide for a grass grub, C. zealandica based on the bacterium S. entomophila [139] . These bacteria were first obtained from sick grubs, cultured and discovered to cause amber disease in insects. Bacterial septicaemia is accompanied by a rapid breakdown of the cadaver and release of bacteria back into soil. The first simple identifications established the bacteria as non-spore-forming members of the genus Serratia (Enterobacteriaceae). Subsequently it was established that S. entomophila and S. proteamaculans bacteria, both of which could occur in pathogenic and nonpathogenic forms, populated New Zealand pasture soils. Unlike other soil bacteria, Serratia can grow on media rich in thalium salts, and caprylate thallous agar provides an excellent selective medium for isolation [140] . To develop these bacteria as biopesticides is interesting, because they can be cultured through in vitro fermentation and can be applied back to soil causing disease [141] . in tobacco hornworm (M. sexta) by 25% as compared with the parent wild-type strain [75] . The remarkable extent to which virulence can be increased is shown in the case of the scorpion toxin (AaIT) expressed in the M. anisopliae strain ARSEF 549. The modified fungus gave the same mortality rates in M. sexta at 22-fold lower spore doses than the wild type, and survival times at some doses were reduced by 40% [76] . Similar results have been with mosquitoes with a 9-fold reduction in LC50 and coffee berry borer beetle with a 16-fold reduction in LC50 [77] .
Production and Development
Some microbial biopesticides are easy to produce and develop and can be manufactured using simple and inexpensive technologies. The BVs and EPN can be produced in vivo in insects and entomopathogenic fungi, such as Beauveria and Metarhizium, are produced on grains.
Such simple technologies are useful for developing countries where a substantial demand exists for local production and distribution at the farmers' level. However, production methods are only one aspect of the development of a new microbial biopesticide [78] , and one has to solve potential problems associated with contamination, formulation potency, attenuation of pesticidal activity and shelf life. All these aspects require equipment, expertise, material and capital. As such, small entrepreneurs, particularly in the developing world are often not able to meet these requirements and to some extent, a similar situation persists in small production facilities in the developed world [79] [80] [81] [82] . It is estimated that to develop a single product costs >US$25 million from discovery to formulation development in order to reach a farmer for application. In the microbial biopesticides field, the major emphasis has been on Bacillus thuringiensis. Frankenhuyzen [83] has recently documented that to date 125 of the 174 holotype known toxins have been tested against 163 test species. However, the products are classified according to their formulation. These formulations are emulsions, encapsulations and granules (for agriculture and forestry); wettable powders (for gardens); and briquettes (for aquatic systems). There are now many formulations based on spore-crystal complexes, which need to be ingested by the pests for toxic action. The spore-crystal complexes are required to be carried by suitable excipients that would protect the spore crystal and at the same should be palatable to the insect, i.e. with increased feeding preference. A good example of such a formulation is of Cry protein from B. thuringiensis with an attractant glycoprotein [84] for killing fire ants. Some designs are also known for beet armyworm, Spodoptera exigua [85] . However, a classical case study is the discovery and commercialization of a bacterial product for a grass grub, Costelytra zealandica based on the bacterium Serratia entomophila (see Box 3). Many biodegradable materials have been used to prepare formulations, including liquid or solid carriers, surfactants, adjuvants, adherents, dispersants, stabilizers, moisturizers, attractants and protective agents [86] . Long shelf life and reliable efficacy, which are affected by moisture, are the two basic impediments for commercialization of a bacterial biopesticide and strategies to develop delivery materials with dynamic vapour sorption properties have been worked out in a recent study where three biopesticide delivery systems, THE -G, PEC-G and PESTA,
Box 4 Fungal Biopesticides: A Case Study
Locusts and grasshoppers are extremely damaging pests in various parts of the world. The largest locust swarm was reported in Kenya in 1954, covered more than 1000 km2, contained 40 000 million insects, and weighed 80000 tonnes. One tonne of locusts eats as much food in one day as about 2500 people [144] . Similarly, grasshoppers do more crop damage on an average. The main control measure against locusts and grasshoppers has been broad-spectrum pesticides. For instance, between 1986 and 1989, donors and national governments spent US$200 million spraying 10 million ha with 15 million litres of the broad spectrum insecticides fenitrothion and malathion [145] ; the pesticides having hazardous environmental impacts. In view of such hazards, the US Agency for International Development In the first 10 years, the LUBILOSA project spent US$15 million and produced an environmentally benign alternative to chemical pesticides. Demonstration trials and farmer participatory trials have been conducted in most Sahelian countries in collaboration with the national programmes [146] . A project in Australia has used LUBILOSA research data to develop a biopesticide against Australian locusts [147] . The product kills 80% of insects within 1 to 3 weeks. A company is licensed to manufacture the biopesticide, which has been registered in South Africa under the name Green Muscle®. This consortium of donors has recently funded a fourth phase to "steward" the LUBILOSA biopesticide to higher adoption rates and greater impact.
As such, LUBILOSA may well be a template for much more of the activities of the Consultative Group on International Agricultural Research (CGIAR) in the future. Hence, an analysis of the impacts that LUBILOSA has had, could have in the future, and how this impact has and can be achieved, can teach us a great deal about public-private partnerships and the management of impact-focused research [148] .
were analysed by dynamic vapour sorption analysis. The objective of this study was to demonstrate the moisture sorption profile of each system in air at 25°C and a relative humidity (RH) ranging from 0 to 90%. These studies have revealed that moisture loss retards the activity in the range of 2.3-3.4 times [87] , thus suggesting the implications relative to moisture distribution. In the case of fungal biopesticides, a system for mass production of conidia has been standardized after evaluating different solid matrices such as rice, wheat bran and mijo grains, contained in both, high-density polyethylene bags and aluminium trays, supplemented with different organic nitrogen sources and inoculated with different inoculum types [88] . Once the matrices are established, where the greatest conidia production per gram of substrate is obtained, the conidia are separated and used as an active starter for elaborating the biopesticide prototypes. Recently, a complex coacervate formulation was developed for Colletotrichum truncatum, a bioherbicidal fungus against scentless chamomile, and tested in the greenhouse. A two-step process was developed to formulate C. truncatum conidia. Firstly, an invert emulsion preparation of C. truncatum conidia in non-refined vegetable oil with the aid of a surfactant was prepared, followed by encapsulating the C. truncatum conidia invert emulsion by complex coacervation. Formulation ingredients included non-refined vegetable oils, surfactants, proteins and carbohydrates. Most formulation ingredients considered and tested in this study were compatible with C. truncatum, with no significant reduction in conidial germination and mycelial growth. The surfactant soya lecithin promoted the greatest retention of C. truncatum conidia (88%) in the invert emulsion. In greenhouse studies, scentless chamomile disease was controlled significantly [89] . This example implies that fungal microbial biopesticides could be very useful in field situations if appropriate formulations and specific delivery systems are developed. However, specific example of successful fungi-based product is the LUBILOSA programme (see
Box 4).
The use of wild-type biopesticides in terms of registration could be more appropriate as they will require a demonstration of efficacy and safety issues will be of less concern. There is evidence to show the potential of wildtype BVs [90, 91] . For instance, process patent is available for production of BVs via fermentation in Australia [92] , which targets the Helicoverpa pest species and accounts for a US$3.2 billion per annum market. Production costs suggested allows to target Helicoverpa pest species in areas where this pest is resistant to most low-cost chemical options (15 $/ha), and where only more expensive chemicals are in use (30-50 $/ha). These studies suggest that wild-type products with improved yields can compete on cost alone in all markets, including extensive markets in India and China. Therefore, bioreactor-based production of BVs requires more focus, which may be Box 5 Viral biopesticides: A case study Control of the velvetbean caterpillar, A. gemmatalis, in soyabean in Brazil is an interesting case study where one can take an advantage of a naturally occurring nucleopolyhedrosis virus (AgMNVP) against a pest. This virus is currently used on approximately two million hectares of soyabeans in Brazil and is one of the largest programmes worldwide for the use of a viral pathogen to control a pest of a single crop [149] .
Although implementation of the programme began in the 1982/83 season, it gained momentum with the development of a wettable powder formulation in 1986, which was then taken up by private companies for commercial production; use of AgMNVP reached 1.5 million ha in 1995. Field production of the virus became a big business in Brazil, involving different persons and small companies specialized in selling AgMNPV-killed caterpillars [150] . A breakthrough in commercial pilot laboratory production occurred at Embrapa Soybean in Londrina in 2002. In the production system of the virus, eggs are obtained daily in adult oviposition rooms, and larvae reared in separate rooms up to fourth instar in 500 ml cardboard cups containing an insect diet. Daily 3% of the larvae are transferred to plastic trays with diet and vermiculture to obtain pupae and maintain the insect colony. The rest (97%) of the fourthh instars are taken to the virus production laboratory, where they are transferred to plastic trays containing AgMNVP-treated diet. Seven days later, dead larvae are collected into plastic bags with a modified hand vacuum cleaner. The larvae are then taken to a storage room for further processing and formulation of the product. This commercial laboratory production started in the end of 2004 and produces 800 000-1 000 000 larvae/day, resulting in agMNVP to treat 1.8-2.0 million ha/year [149] . It is expected that AgMNVP use may reach to 4.0 million ha/year by 2012. This programme in Brazil has been successful because of its implementation of a soyabean IPM programme, proactive activities of extension units, high virulence of pathogen to the host and efficient horizontal transmission, continued exposure of pest to AgMNVP and ability to produce large quantities of virus under field conditions at a very low cost.
Box 6 Nematode biopesticides: A case study
Molluscs are pests for which few biological control agents are available. Therefore, this is a case of a successful commercial development of a novel species of nematode with specific activity against slugs. A nematode, P. hermaphrodita has been isolated from a destructive grey field slug species D. reticulatum [151] , which develops a very characteristic swelling in the rear half of their mantle at an early stage of infection, and following death, many large nematodes of 3 mm size can be seen feeding on the cadaver. This nematode has a curious ability to adopt necromenic life cycle in larger slugs, in which the Us enter the slug's body cavity and remain dormant there without doing harm until the slug dies, when the juveniles develop and reproduce, feeding on the cadaver. When the nematode enters smaller slugs, it develops directly, causing disease and death of the host. An interesting thing about nematodes such as EPN is their mutalistic symbiosis with Gram-negative entomopathogenic bacteria such as Xenorhabdus and Photorhabdus, but this is not true in case of P. hermaphrodita. This nematode is capable of growth on a wide range of bacteria, but nematodes grown on different bacteria differ dramatically in virulence. The reason for this is unknown [152] . However, the use of a bacterium, Moraxella osloensis that produced consistently pathogenic nematodes for mass production in the variety of field experiments has been highly significant and economically viable. The product based on this nematode is now making a transition from being a garden and protected crop treatment to being used in field vegetables [153] . The very famous product Nemaslug is sold in UK and each commercial packet contains 12 million dauer EPN can be commercially mass-produced in vivo or in vitro, in solid or in liquid culture, each system having its own advantages and disadvantages relative to costs of production, investments, quality of products and technology. One of the good examples is a successful commercial development of a novel species of nematode with specific activity against slugs where a nematode, Phasmarhabditis hermaphrodita has been isolated from a destructive grey field slug species Deroceras reticulatum (see Box 6) . However, there are many challenges in making production more reliable and economical [93] and process parameters require more research, particularly the ones that influence the bacteria as well as the nematodes in liquid cultures. Another significant factor is phase variation of the symbiotic bacteria, shifting from primary to secondary forms that lead to unpredictable yields [94] .
As of today, a huge number of Us is required for pest management within a location; if these numbers could be decreased, market opportunities for EPNs will definitely increase.
In terms of the formulation development, the ability to formulate viruses for application with commonly available implements makes viruses more attractive as biological control agents. Commercially, dried formulations have an advantage over liquid formulations for storage and handling. However, dry formulations have constraints such as dustiness, inhalation risk and storage. Lyophilization has been the most common method for stabilizing viruses but is an expensive procedure [95] . Another method has been the encapsulation with cornstarch to prepare granular formulations. The lignin formulations have demonstrated extended residual activity in both laboratory and field experiments [96, 97] . Spray drying [98] has been used for B. bassiana to microencapsulate conidia of this entomopathogenic fungus at low temperature [99, 100] . In addition, various polymers are used to prolong the activity of the conidia and improve their shelf life. The bestencapsulated product, composed of 10% dextrin, 10% skimmed milk and 5% polyvinylpyrrolidone K90 as the coating material, had a shelf life of 6 months at 4°C [101] . However, ingredient selection, processing techniques and moisture content still hinder the development and production processes of virus-based microbial biopesticides.
Some delivery systems through drip irrigation systems have also been studied recently. The suspendible entomopathogenic fungi and EPN evaluated through drip lines are a viable alternative for application of water-soluble and insoluble materials; however, the discharge rates need to be determined for uniformity of the delivery [102] .
Nematode formulations, however, need to be tailored and require the studies in physiological chemistry of nematode and its ecology and behaviour. A recent overview of nematode-based formulations [103] advocates the use of many types of formulations, including water-dispersable granules. However, water-dispersable granular formulations were not successful on a larger scale [104] : dominant and successful ones were clay-and gel-based formulations.
Resistance to Microbials
Among the various groups of microbial pathogens, development of resistance has been most frequently reported in the case of B. thuringiensis. Within the last few years, at least 16 insect species have been identified that exhibit resistance to B. thuringiensis 8-endotoxins under laboratory conditions and field-evolved resistance has been documented in noctuids such as Spodoptera frugiperda, Busseo la fusca and H. zea [105] . Reports of development of resistance in field populations of Plutella xylostella are essentially from the countries where Bacillus thuringiensis is extensively used, i.e. China, Japan, Phillippines, Malaysia, India and North America. To avoid this resistance problem, genetic engineering was considered as a useful tool where microbial genes from B. thuringiensis were transferred to plants to produce transgenics and today we have B. thuringiensis cotton and B. thuringiensis maize available in 13 and 9 countries, respectively, grown on 42.1 million ha of land [106] . The development of such transgenics was seen as a panacea in terms of microbial control of pests; however, field resistance in H. zea as a result of an increase in the frequency of resistance alleles is alarming [107] . The field-evolved insect resistance to B. thuringiensis crops and various Opender Koul 19 aspects related to resistance monitoring methods have been comprehensively reviewed recently [105] ; obviously more prominent in lepidopterans [108, 109] . Factors associated with field resistance are the failure to use highdose B. thuringiensis cultivars and lack of a sufficient refuge.
While implementation of the high-dose/refuge insect resistance management strategy has been successful in delaying field resistance to Bt crops [109] , gene pyramiding is another approach used to try and address the emerging resistance problem [110, 111] . Pyramiding means the stacking of multiple genes so that more than one toxin is expressed in the transgenic plant. However, gene-pyramiding needs to be sustainable and no crossor multiple resistances should occur. The problem of developing multiple resistance cannot be summarily ignored as in the end they would render such strategies ineffective. Asymmetrical cross-resistance between B. thuringiensis toxins Cry1Ac and Cry2Ab in pink bollworm [112] suggests that it is important to incorporate the potential effects of such cross-resistance in resistance management plans so as to help to sustain the efficacy of pyramided B. thuringiensis crops. Current evidence suggests that gene pyramiding may not be a sustainable strategy per se; therefore, other management strategies such as refugia, use of predators and parasitoids and crop rotation strategies need to be incorporated in the management plans [110, 112] . Transgenic plants that control insects via RNA interference are going to be a reality soon [113, 114] , which will broaden further the scope of transgenics and can help in minimizing the drawbacks of resistance. Some recent studies have shown that toxinbinding proteins such as cadherin promote B. thuringiensis toxicity [115] . These binding proteins facilitate toxin oligomerization and thus modify the B. thuringiensis toxin, which can prevent the resistance in comparison with the standard B. thuringiensis toxins. The studies demonstrate that the toxicity of B. thuringiensis toxin Cry1Ab is reduced by cadherin gene silencing with RNA interference in M. sexta. The toxins that had cadherin deletion mutations killed cadherin-silenced M. sexta and B.-thuringiensisresistant Pectinophora gossypiella [115] .
Recently, resistance in a baculovirus in the field has been found in Europe where Cydia pomnella GV is one of the main components of the codling moth control.
C. pomonella GV in apple orchards has led to a high degree of resistance in some populations [116, 117] . This is the first documented instance of field resistance to a commercially applied baculovirus [118] . Apparently, this is either the result of the overuse of the product or the predominant control strategy applied. However, there do not seem to be any reported examples of field development of resistance to entomopathogenic fungi or nematodes [119] . However, there is evidence to demonstrate the existence of natural resistance mechanisms in insects against fungi [120, 121] and nematodes [122] , suggesting that resistance to these pathogens cannot be summarily ignored.
Future Perspectives
Owing to some of the early successes and the continuing growth of biopesticide market, expectations for the performance of microbial biopesticides have been high. However, there are many challenges that will need to be overcome. Firstly, questions have been raised about the barriers that research patents place on humanitarian uses of patented technologies as well as on the conduct and availability of publicly funded research results [1 23, 1 24] . Secondly, current regulatory guidelines are inadequate, while information on the uptake of microbial control strategies must be collated and shared with the rest of the field. Furthermore, to implement local production schemes in developing countries, intervention at the national and international level will be important.
Thirdly, there is also a need to look into the ecological relevance vis-à-vis the use of microbial biopesticides. Some recent studies reveal that pattern and impact of these toxins varies from species to species, depending on the ecosystem, the route of exposure and the non-Bt control against which effects are quantified [125] . As such, the effect of microbial biopesticides on microbial communities must be carefully monitored [126] .
In fact, there is a need for well-defined selection criteria and a complete process description for the development of a microbial pest control product. For a commercial microbial product, three specific criteria for selection are required, i.e. toxicity, production efficiency and safety of the product. That means while screening process toxicity of the product will be relative to dose rate, mode-ofaction, speed of kill, host range, sensitivity to abiotic factors and persistence. Secondly, mass production will be critical criteria and should be a high-yield-oriented process. Thirdly, safety of product will be essential in relation to registration requirements and the costs involved.
An important question, however, is when are microbial biopesticides appropriate? Generally, scientists and biocontrol companies seem to develop their products without a well-developed plan, though the approach should be to develop a product to solve a problem or to grasp an opportunity. It is essential to make a detailed characterization like which pest, crop, region, time of the problem, solutions available, acceptable costs and market potential [1 27] . If these aspects are considered and details are provided, a potential microbial product could be obtained. A good example is the Lubilosa (see Box 3), which was a problem-solving project. Therefore, recommended steps to obtain a good microbial pest control product would be: (i) collection of isolates and identification of perfect isolate, (ii) laboratory screening for efficacy, (iii) assessment of production efficiency, (iv) mode-of-action and toxicological properties, (v) glasshouse trials and (vi) evaluation of efficacy under commercial conditions. If all these factors are considered, success is inevitable, perseverance to develop such products will be rendered less risky, and questions such as, 'how to walk a tightrope' [128] or 'The long and winding road -discovery to commercial product: are we there yet?' [1 29] will be answered.
In order to increase the utility of microbial pathogens in EBIPM programmes, systematic surveys are required in different agroecological zones to identify naturally occurring pathogens. Detailed studies are necessary on the properties, mode-of-action and pathogenicity of such organisms. Ecological studies on the dynamics of diseases in insect populations are necessary because the environmental factors play a significant role in disease outbreaks and ultimate control of the pests. It is expected that with the recent advancements in microbial research coupled with dedicated efforts from extension specialists, farmers, pest management regulators and the general public, microbial biopesticides could play a prominent role in future EBIPM and AWPM programmes. As mentioned above, structured project plans are required to achieve the goal. The roadmap to successful development and commercialization of a microbial pest control product is amply illustrated in new flow diagrams recently, which provide the details of various phases' involved and output information leading to consecutive steps for decision making and ultimately the market potential [127] .
With respect to the ecology of microbial control agents, this has been a major concern over the years that has remained little researched. So far, biotechnology and genetics has (understandably) driven the progress in microbial control but there has been negligible interest in how these organisms have evolved to survive in nature.
For example, the means by which B. thuringiensis survives in nature have yet to be proven [1 30] , and the costs and benefits of cry gene possession are unclear. It is evident, however, from the plethora of cry genes that exist that gene duplication and exchange are commonplace. In fact, its spore-forming nature makes it uncertain with regard to how much vegetative existence B. thuringiensis has and so how much mutation and recombination can take place. It certainly has a vegetative existence in at least some insect species, in which it causes pathology through conjugation [1 31 ]. An interesting aspect would be to see if the same lack of association between sequence types and episomal factors are evident in other environments where B. thuringiensis can be demonstrated to have a vegetative existence [1 32] . A recent study [1 33 ] with seedlings of clover (Triflorium hybridum) shows colonization by B. thuringiensis when spores and seeds were co-inoculated into soil. Both a strain isolated in the vegetative form from the phylloplane of clover and a laboratory strain were able to colonize clover to about 3 times higher density when seeds were sown in sterile soil rather than in non-sterile soil. A strain lacking the characteristic insecticidal crystal proteins produced a similar level of colonization over a 5-week period as the wild-type strain, indicating that crystal production was not a mitigating factor during colonization. A small plasmid, pBC16, was transferred between strains of B. thuringiensis when donor and recipient strains were sprayed in vegetative form onto leaves of clover and pak choi (Brassica campestris var. chinensis).
The rate of transfer was about 0.1 transconjugants/ recipient and was dependent on the plant species. The levels of B. thuringiensis that naturally colonized leaves of pak choi produced negligible levels of mortality in third instar larvae of Pieris brassicae feeding on the plants. Considerable multiplication occurred in the excreted frass but not in the guts of living insects. Spores in the frass could be a source of recolonization from the soil and be transferred to other plants. These findings illustrate a possible cycle, not dependent on insect pathology, by which B. thuringiensis diversifies and maintains itself in nature. The majority of research that has been carried out on B. thuringiensis has related to its insecticidal toxins and its survival in nature may not always depend on insect pathology. It can colonize seedlings from spores in the soil, exchange genetic information on the phylloplane, and an appreciable multiplication can occur in the frass of insects that it did not kill [133] . A cycle of transmission and survival can thus be envisaged. The enigma, however, is the cost and benefit of crystal protein production in its ecology, particularly when in competition with non-crystal protein producing bacteria such as B. cereus. Therefore, longer-term studies in nature or in microcosms and their survival in soil and plants in the presence of susceptible and non-susceptible invertebrates are required [133] .
The mechanism of resistance, specifically for Cry proteins, is a matter of concern. Recently, a database consisting of 12519 high-quality sequences have been developed from the larval gut of European corn borer. This obviously can provide basis for future research to develop gut-specific DNA microarrays to analyse the changes of gene expression in response to B. thuringiensis protoxins/toxins and the genetic difference(s) between Bt resistance and susceptible strains [134] . In fact, 52
candidate genes have been identified that may be involved in Bt toxicity and resistance. For instance, out of selected genes, five genes with decreased expression and ten with increased expression in Cry1Ab-resistant strain of European corn borer may help in identifying the genes involved in Bt resistance that could provide new leads into the mechanism of Cry1Ab resistance in these insects [134] .
Commercialization is the final and most difficult step in the development of a microbial product. The most critical factors are developmental cost and time to market. Costs amount to US$14 -21 million for a new entrepreneur and the time to market including registration is no less than 5-7 years. Therefore, to examine all these critical factors in the successful commercialization of microbial pest control products is essential in the developmental process of a product and these critical factors have been comprehensively discussed recently [127] .
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